Literature DB >> 17963866

Contraceptive and hormonal properties of the stem bark of Dysoxylum binectariferum in rat and docking analysis of rohitukine, the alkaloid isolated from active chloroform soluble fraction.

Govind Keshri1, Ravi Mohan Oberoi, Vijai Lakshmi, Kartikay Pandey, Man Mohan Singh.   

Abstract

BACKGROUND: This study was aimed to investigate the pregnancy interceptive activity of the stem bark of Dysoxylum binectariferum Hook. f. administered during the pre- and peri-implantation periods and immediately after implantation by oral route in adult female Sprague-Dawley rats. STUDY
DESIGN: Ethanolic extract and its fractions were administered to female rats on Days 1-10, Days 1-7, Days 1-5 or Day 1 postcoitum by oral route. At autopsy on Day 12, the number and status of corpora lutea and implantations were recorded. For estrogenic activity, ovariectomized immature rats received the test extract or the vehicle once daily for 3 days and at autopsy on Day 4, uterine weight and status of vaginal opening and extent of vaginal cornification were recorded. For antiestrogenic activity, the extract was administered along with ethinyl estradiol. Docking analysis of rohitukine, the alkaloid isolated from active chloroform soluble fraction, to estrogen receptor (ERalpha) was conducted using AutoDock 3.0.5 on a Linux workstation.
RESULTS: The ethanolic extract intercepted pregnancy in rats at a daily dose of 500 mg/kg on Days 1-7 postcoitum. On fractionation, the activity was localized in the chloroform fraction, which inhibited pregnancy in all females at the 35-mg/kg dose on Days 1-7, at the 50-mg/kg dose on Days 1-5 or at the single 300-mg/kg dose on Day 1 postcoitum. Chromatography of this fraction yielded an alkaloid, rohitukine, which prevented pregnancy at the 10-mg/kg dose administered on Days 1-7 but was partially (45%) effective at this dose when administered during the entire preimplantation period and ineffective even at 10 times this dose when administered only on Day 1 postcoitum, except that there was a significant reduction in implantation number in pregnant females. While the active chloroform soluble fraction was devoid of any estrogen agonistic or antagonistic properties, a mild uterotropic effect without induction of premature opening of vagina or cornification of vaginal epithelium was observed in rohitukine at the 10-mg/kg dose. Rohitukine, with an almost similar molecular size (mol. wt. 305) as 17beta-estradiol, fits ideally into the hydrophobic pocket of ER. While it does not appear to simultaneously interact with GLU353, ARG394 and HIS524 as estradiol to elicit frank estrogenic response, different conformations of the ligand or its metabolite(s) might acquire geometry with phenolic groups at C-3', C-5 and C-7 positions disposed in a fashion to interact with active site(s) of ER, which might be responsible for its contraceptive and/or weak uterotropic effects. The absence of a basic side chain directed toward the antiestrogen binding site (ASP351) on the receptor appears to be responsible for the lack of any estrogen antagonistic activity.
CONCLUSIONS: Findings demonstrate the antifertility activity of the ethanolic extract of D. binectariferum, its chloroform soluble fraction and rohitukine. Efforts are being made to enhance the anti-implantation activity of rohitukine by structural modifications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963866     DOI: 10.1016/j.contraception.2007.07.009

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Pharmacological evaluation of the efficacy of Dysoxylum binectariferum stem bark and its active constituent rohitukine in regulation of dyslipidemia in rats.

Authors:  Sunil K Mishra; Shashi Tiwari; Shishir Shrivastava; Ravi Sonkar; Vaibhav Mishra; Sunil K Nigam; Anil K Saxena; Gitika Bhatia; Snober S Mir
Journal:  J Nat Med       Date:  2014-03-28       Impact factor: 2.343

2.  Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo.

Authors:  Salil Varshney; Kripa Shankar; Muheeb Beg; Vishal M Balaramnavar; Sunil Kumar Mishra; Pankaj Jagdale; Shishir Srivastava; Yashpal S Chhonker; Vijai Lakshmi; Bhushan P Chaudhari; Rabi Shankar Bhatta; Anil Kumar Saxena; Anil Nilkanth Gaikwad
Journal:  J Lipid Res       Date:  2014-03-19       Impact factor: 5.922

3.  Evaluation of In Vitro Uterotonic Activities of Fruit Extracts of Ficus asperifolia in Rats.

Authors:  Pierre Watcho; Esther Ngadjui; Pepin Alango Nkeng-Efouet; Telesphore Benoît Nguelefack; Albert Kamanyi
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-13       Impact factor: 2.629

Review 4.  Anticancer Alkaloids from Trees: Development into Drugs.

Authors:  Tasiu Isah
Journal:  Pharmacogn Rev       Date:  2016 Jul-Dec

5.  A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, alleviates ovariectomized-induced osteoporosis in rats and inhibits growth of breast and ovarian cancer cells.

Authors:  Swaha Satpathy; Arjun Patra; Muhammad Delwar Hussain; Mohsin Kazi; Mohammed S Aldughaim; Bharti Ahirwar
Journal:  PLoS One       Date:  2021-01-14       Impact factor: 3.240

6.  The Chromone Alkaloid, Rohitukine, Affords Anti-Cancer Activity via Modulating Apoptosis Pathways in A549 Cell Line and Yeast Mitogen Activated Protein Kinase (MAPK) Pathway.

Authors:  Mohd Kamil; Pooja Jadiya; Saba Sheikh; Ejazul Haque; Aamir Nazir; Vijai Lakshmi; Snober S Mir
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

7.  Estrogenic Effect of Scoparia dulcis (Linn) Extract in Mice Uterus and In Silico Molecular Docking Studies of Certain Compounds with Human Estrogen Receptors.

Authors:  Khamhee Wangsa; Indira Sarma; Purbajyoti Saikia; Dhanabalan Ananthakrishnan; Hirendra Nath Sarma; Devadasan Velmurugan
Journal:  J Reprod Infertil       Date:  2020 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.